• Acne

    The main signs of Acne vulgaris are areas of scaly red skin (seborrhea), blackheads and whiteheads (comedones), and inflammatory lesions or pimples, such as pinheads (papules), nodules (large papules) and pustules, as well as cysts, and possible scarring.

    Duration:  12 weeks.

    Number of visits:  4 office visits.

    Compensation:  $200 for completing the study.

    Qualified participants: Must be 12 to 40 years old and have at least moderate acne on the face.

  • Osteoarthritis of the Knee

    Osteoarthritis of the Knee – Arthritis means “joint inflammation.” It causes pain and swelling in the body’s joints, such as the knees. There are many types of arthritis; osteoarthritis is more likely to develop as people get older.

    The purpose of this study is to evaluate the analgesic efficacy on pain with walking of the study drug compared to placebo, at 12 weeks, when administered as a single intra-articular (IA) injection into the index knee.

    Duration:  52 weeks.

    Number of visits:  11 office visits.

    Compensation:  $885 for completing the study.

    Qualified participants: Must be 40 to 95 years old and have moderate to severe Osteoarthritis (OA) of the knee.

  • HIV

    HIV is a viral infection that damages the immune system and makes you susceptible to other serious infections. The study medication belongs to the monoclonal antibody class of medicines. Monoclonal antibodies are synthetic versions of the disease-fighting proteins (antibodies) that are naturally produced by the body. Antibodies that are normally present in the blood typically react to foreign organisms or materials (bacteria, viruses, etc.). However, the study medication binds to a protein (CCR5) that is one of two receptors found on certain human immune cells (blood cells that fight infections) and are the pathway by which the HIV-1 virus infects the cell. When the study medication binds to the CCR5 receptor on these immune cells, HIV cannot attach itself to the cell, and cannot infect the cell. However, it is not expected that the study medication will bind to every CCR5 receptor.

    The purpose of this study is to determine if the study product is safe and if it works to suppress viral load in HIV-1 patients in combination with FDA approved antiretroviral regimens.

    Duration: Treatment phase up to six months.

    Compensation: $85 per completed visit.

    Qualified participants: Men or women 18 years of age or older.
    Have a diagnosis of HIV. Are taking antiretroviral medication for more than 3 months.

  • Rosacea

    Clinical Research Study for Rosacea.

    Rosacea (roe-ZAY-she-uh) is a common skin condition that causes redness and visible blood vessels in your face. It may also produce small, red, pus-filled bumps. … Rosacea can be mistaken for acne, an allergic reaction or other skin problems.

    Duration: 3 months.

    Number of visits:  6 office visits.

    Compensation:  $325 for completing the study.

    Qualified participants: At least 18 years of age and diagnosed with mild, moderate or severe Rosacea.

  • Nocturia

    Nocturia  is defined by the International Continence Society (ICS) as “the complaint that the individual has to wake at night one or more times for voiding (i.e. to urinate).”

    The purpose of this study is to test an investigational medicine to see if it helps with nocturia.

    Duration:  12 weeks.

    Number of visits:  8 office visits.

    Compensation:  $675 for completing the study.

    Qualified participants: Men or women 18 years or older with at least a 6 month history of 2 of more night time urinations.

  • Plaque Psoriasis

    Plaque Psoriasis is the most common form of the disease and appears as raised, red patches covered with a silvery white buildup of dead skin cells or scale.  These patches or plaques most often appear on the scalp, knees, elbows and lower back.  They are often itchy and painful, and they can crack and bleed.

    The purpose of this study is to assess the efficacy of the study medication for the treatment plaque psoriasis.

    Duration:  4 weeks.

    Number of visits:  3 office visits.

    Compensation:  $195 for completing the study.

    Qualified participants: Must be 18 to 80 years of age and have severe itching due to plaque psoriasis.

  • Low Testosterone

    What is Testosterone?

    Testosterone is the male sex hormone that is made in the testicles. Testosterone hormone levels are important to normal male sexual development and functions.

    During puberty (in the teen years), testosterone helps boys develop male features like body and facial hair, deeper voice, and muscle strength. Men need testosterone to make sperm.

    Testosterone levels generally decrease with age, so older men tend to have low blood testosterone levels.

    Purpose of the study:  is to compare the effect of the study medication and placebo on the incidence of major adverse medical event (mace) in middle-age and older men with Low-T who are at risk for cardiovascular disease.

    Duration:  5 years

    Number of visits:  18 office visits and 10 phone calls.

    Compensation:  $1305.00 for completing the study.

    Qualified participants: Men 45 to 80 years of age with low testosterone who have or at risk for having cardiovascular (CV) disease.

  • Osteoarthritis of the Hip

    Osteoarthritis of the Hip– Arthritis means “joint inflammation.” It causes pain and swelling in the body’s joints, such as the knees or hips.  There are many types of arthritis; osteoarthritis is more likely to develop as people get older.

    The purpose of this study is to assess the efficacy of the study medication on pain following an intra-articular (IA) injection in patients with hip osteoarthritis (OA).

    Duration:  36 months.

    Number of visits:  13 office visits.

    Compensation:  750 for completing the study.

    Qualified participants: Must be 40 to 80 years of age and have a diagnoses of osteoarthritis (OA) of the hip.